Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) 5-Year Sharpe Ratio: N/A (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IST:ONCSM Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
68 GF Score
Price ₺115.60
GF Value ₺333.59
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Oncosem Onkolojik Sistemlernayi ve Ticaret AS 5-Year Sharpe Ratio?

The 5-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past five years. As of today (2026-09-21), Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 5-Year Sharpe Ratio is Not available.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS  (IST:ONCSM) 5-Year Sharpe Ratio Explanation

The 5-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past five years. It is calculated as the annualized result of the average five-year monthly excess returns divided by its standard deviation in the five-year period. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS 5-Year Sharpe Ratio Related Terms


IST:ONCSM vs ABT, SYK, MDT: 5-Year Sharpe Ratio Comparison

For the Medical Devices subindustry, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 5-Year Sharpe Ratio, along with its competitors' market caps and 5-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS 5-Year Sharpe Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 5-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Oncosem Onkolojik Sistemlernayi ve Ticaret AS's 5-Year Sharpe Ratio falls into.


IST:ONCSM
68GF Score
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
5-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncosem Onkolojik Sistemlernayi ve Ticaret AS 5-Year Sharpe Ratio Calculation

The 5-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset in the last five years. A stock / portfolio's 5-Year Sharpe Ratio can be calculated by dividing the difference between the five-year average monthly returns of the investment and the risk-free rate, by the standard deviation of the investment returns over the past five years.

Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Overvalued in 2026?

Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock appears to be undervalued. The current stock price of ₺115.60 is trading 65.3% below its estimated GF Value™ of ₺333.59. GuruFocus considers Oncosem Onkolojik Sistemlernayi ve Ticaret AS to be Possible Value Trap.

Key valuation signals for IST:ONCSM:

  • 5-Year Sharpe Ratio: N/A
  • GF Value™: ₺333.59 vs. price of ₺115.60 (65.3% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the IST:ONCSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description

Address Mutlukent Mah. 1988 Cad. No: 12, Cankaya, Ankara, TUR
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.
68GF Score

Get the complete analysis for IST:ONCSM

5-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺115.60
Price
₺333.59
GF Value